Cite
HARVARD Citation
Kamegai, K. et al. (2022). A Fatal Breakthrough COVID-19 Case Following Bendamustine-Rituximab Therapy. International journal of infectious diseases. pp. 85-88. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kamegai, K. et al. (2022). A Fatal Breakthrough COVID-19 Case Following Bendamustine-Rituximab Therapy. International journal of infectious diseases. pp. 85-88. [Online].